Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Oncology

Topics

Mathematics

Materials Science

Medicine

Cancer Oncology

Immunology

Show all topics

DOI

10.1016/s1470-2045(18)30576-x

License

publisher-specific-oa